title: Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole.
authors.affiliation: Eijkman-Winkler Institute for Clinical Microbiology, Utrecht University, The Netherlands. schmitfj@uni-duesseldorf.de
authors.forename: F J
authors.initials: FJ
authors.lastname: Schmitz
authors.forename: J
authors.initials: J
authors.lastname: Verhoef
authors.forename: D
authors.initials: D
authors.lastname: Milatovic
authors.forename: A C
authors.initials: AC
authors.lastname: Fluit
mesh_terms: D018432:Drug Resistance, Multiple; D006801:Humans; D018942:Macrolides / Q000494:pharmacology* / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000188:drug therapy*; D015363:Quinolones / Q000494:pharmacology* / Q000627:therapeutic use; D012680:Sensitivity and Specificity; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D013752:Tetracycline / Q000494:pharmacology* / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D018942:Macrolides; D015363:Quinolones; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D013752:Tetracycline